Philips, headquartered in the Netherlands, is a global leader in health technology with expertise in image-guided therapy. Through its acquisitions of Volcano and Spectranetics, Philips provides advanced cardiovascular tools such as intravascular ultrasound (IVUS), fractional flow reserve (FFR), and instantaneous wave-free ratio (iFR). These solutions support accurate diagnosis and treatment in coronary and peripheral interventions, improving clinical outcomes.